Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

Emil Chteinberg, Suzan Wetzels, Wouter Gerritsen, Lieve Temmerman, Joost van den Oord, Erik Biessen, Anna Kordelia Kurz, Veronique Winnepenninckx, Martin Zenke, Ernst-Jan Speel, Axel zur Hausen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1758835920975621
Number of pages16
JournalTherapeutic Advances in Medical Oncology
Volume12
DOIs
Publication statusPublished - Dec 2020

Keywords

  • apoptosis
  • BCL-2 inhibitor
  • Merkel cell carcinoma
  • Merkel cell polyomavirus
  • PI3K inhibitor
  • BCL-XL
  • EXPRESSION
  • APOPTOSIS
  • POLYOMAVIRUS
  • CHEMOTHERAPY
  • PROTEINS
  • PI3K
  • P53
  • PHARMACOKINETICS
  • MALIGNANCIES

Cite this